This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $779 | To Be Confirmed |
500mg | $1070 | To Be Confirmed |
1g | $1605 | To Be Confirmed |
Cat #: V3900 CAS #: 1134822-09-5 Purity ≥ 98%
Description: Ivacaftor (also known as VX-770; trade name: KALYDECO and Symdeko) is a potent and orally active potentiator of CFTR (cystic fibrosis transmembrane conductance regulator) targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM in fisher rat thyroid cells, respectively.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 550.67 |
---|---|
Molecular Formula | C₃₀H₃₄N₂O₆S |
CAS No. | 1134822-09-5 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 10 mMr |
Water: N/Ar | |
Ethanol: N/A | |
Synonyms | VX770 benzenesulfonate; VX 770 benzenesulfonate; VX-770; Ivacaftor; Trade name: KALYDECO. |
Protocol | In Vitro | Ivacaftor (10 µM) increases the PC secretion activity by 3-fold for ABCB4-G535D, 13.7-fold for ABCB4-G536R, 6.7-fold for ABCB4-S1076C, 9.4-fold for ABCB4-S1176L, and 5.7-fold for ABCB4-G1178S. Ivacaftor corrects the functional defect of ABCB4 mutants |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.8160 mL | 9.0798 mL | 18.1597 mL | 36.3194 mL |
5mM | 0.3632 mL | 1.8160 mL | 3.6319 mL | 7.2639 mL |
10mM | 0.1816 mL | 0.9080 mL | 1.8160 mL | 3.6319 mL |
20mM | 0.0908 mL | 0.4540 mL | 0.9080 mL | 1.8160 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.